Doxycycline Is Anti-Inflammatory and Inhibits Staphylococcal Exotoxin-Induced Cytokines and Chemokines
Open Access
- 1 November 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (11) , 3630-3633
- https://doi.org/10.1128/aac.47.11.3630-3633.2003
Abstract
Proinflammatory cytokines mediate the toxic effect of superantigenic staphylococcal exotoxins (SE). Doxycycline inhibited SE-stimulated T-cell proliferation and production of cytokines and chemokines by human peripheral blood mononuclear cells. These results suggest that the antibiotic doxycycline has anti-inflammatory effects and is therapeutically useful for mitigating the pathogenic effects of SE.Keywords
This publication has 26 references indexed in Scilit:
- Toxic Shock Syndrome and Bacterial Superantigens: An UpdateAnnual Review of Microbiology, 2001
- Inhibition of MMP Synthesis by Doxycycline and Chemically Modified Tetracyclines (CMTs) in Human Endothelial CellsAdvances in Dental Research, 1998
- Inhibition of Toxic Shock Syndrome Toxin-I-Induced Cytokine Production and T Cell Activation by Interleukin-IO, Interleukin-4, and DexamethasoneThe Journal of Infectious Diseases, 1995
- Role of Superantigens in Human DiseaseThe Journal of Infectious Diseases, 1993
- Signal Transduction by Microbial Superantigens via MHC class II MoleculesImmunological Reviews, 1993
- Superantigens and Their Potential Role in Human DiseasePublished by Elsevier ,1993
- T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.The Journal of Experimental Medicine, 1992
- Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein.Proceedings of the National Academy of Sciences, 1991
- Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.Proceedings of the National Academy of Sciences, 1989
- Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.Proceedings of the National Academy of Sciences, 1989